SCHEMBL6580798

SCHEMBL6580798

COc1ccc(-c2nc(-c3cccc(C=O)c3)n(CC(O)CO)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 15/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581092 0.96 NR1H2 (0.45) AVPR1BHDAC1HDAC8NR1H2NR1H3
SCHEMBL6578727 0.87 NR1H2 (0.43) AVPR1BNR1H2NR1H3TSHRNPC1
SCHEMBL6580979 0.86 NR1H2 (0.43) AVPR1BNR1H2NR1H3TSHRNPC1
SCHEMBL6580805 0.84 TGM2 (0.51) AVPR1BNR1H2NR1H3KDM4EALDH1A1
SCHEMBL6580974 0.84 NR1H3 (0.43) AVPR1BNR1H2NR1H3TSHRNPC1
SCHEMBL6581299 0.83 NR1H2 (0.45) AVPR1BNR1H2NR1H3KDM4EALDH1A1
SCHEMBL6580402 0.83 NR1H3 (0.47) AVPR1BNR1H2NR1H3TSHRNPC1
SCHEMBL6578252 0.83 TSHR (0.47) AVPR1BNR1H2NR1H3ALDH1A1LMNA
SCHEMBL6581102 0.83 NR1H3 (0.57) AVPR1BNR1H2NR1H3ALDH1A1LMNA
SCHEMBL6580838 0.82 TSHR (0.44) AVPR1BNR1H2NR1H3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed